Effect of estradiol valerate alone or in association with cyproterone acetate upon vascular function of postmenopausal women at increased risk for cardiovascular disease.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Maturitas

• Publication date

  2001-12-14

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0378-5122(01)00242-0PMID 11731185
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Natural progesterone, but not medroxyprogesterone acetate, enhances the beneficial effect of estrogen on exercise-induced myocardial ischemia in postmenopausal women.

  2000cited by this paper
• Estrogen replacement reverses endothelial dysfunction in postmenopausal women.

  1998cited by this paper
• Comparative effect of continuos combined hormone replacement therapy regimens on brachial artery blood flow

  1998cited by this paper
• Medroxyprogesterone acetate antagonizes inhibitory effects of conjugated equine estrogens on coronary artery atherosclerosis.

  1997cited by this paper
• Hormonal, metabolic, and cellular influences on cardiovascular disease in women

  1997cited by this paper
• Effects of menopause on trends of serum cholesterol, blood pressure, and body mass index.

  1996cited by this paper
• Estrogen acutely increases peripheral blood flow in postmenopausal women.

  1995cited by this paper
• 17 beta-Estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease.

  1995cited by this paper
• 17β-Estradiol Attenuates Acetylcholine-Induced Coronary Arterial Constriction in Women but Not Men With Coronary Heart Disease

  1995cited by this paper
• Estrogen and the blood vessel wall

  1994cited by this paper
• Endothelial-dependent coronary vasomotor responsiveness in postmenopausal women with and without estrogen replacement therapy.

  1994cited by this paper
• Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women.

  1994cited by this paper
• Nitric oxide accounts for dose-dependent estrogen-mediated coronary relaxation after acute estrogen withdrawal.

  1994cited by this paper
• Acute Vascular Effects of Estrogen in Postmenopausal Women

  1994cited by this paper
• Hypertension in women: what is really known? The Women's Caucus, Working Group on Women's Health of the Society of General Internal Medicine.

  1991cited by this paper
• Estrogen monotherapy and combined estrogen-progestogen replacement therapy attenuate aortic accumulation of cholesterol in ovariectomized cholesterol-fed rabbits.

  1991cited by this paper
• Estrogen and coronary heart disease in women

  1991cited by this paper
• Estrogen and progesterone replacement therapy reduces low density lipoprotein accumulation in the coronary arteries of surgically postmenopausal cynomolgus monkeys.

  1991cited by this paper
• Estrogen modulates responses of atherosclerotic coronary arteries.

  1990cited by this paper
• Ovarian hormones and the circulation.

  1990cited by this paper
• Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys. Lack of an effect of added progesterone.

  1990cited by this paper
• Progesterone receptors in the human heart and great vessels.

  1988cited by this paper
• Effect of 17 beta-estradiol on endothelium-dependent responses in the rabbit.

  1988cited by this paper
• Postmenopausal estrogen use and coronary atherosclerosis.

  1988cited by this paper
• Menopause and the risk of coronary heart disease in women.

  1987cited by this paper

• THE ASSOCIATION OF BIOMARKERS OF ENDOTHELIAL DYSFUNCTION AND DISORDERS OF MYOCARDIAL PERFUSION

  2017cites this paper
• Effect of hormone replacement therapy with the anti-mineralocorticoid progestin Drospirenone compared to tibolone on endothelial function and central haemodynamics in post-menopausal women.

  2017cites this paper
• Hormonersatztherapie nach WHI-und Million Women Study-Konsequenzen für die Praxis

  2017cites this paper
• Novel agents targeting nitric oxide.

  2012cites this paper
• Low-dose estrogen and drospirenone combination: effects on glycoinsulinemic metabolism and other cardiovascular risk factors in healthy postmenopausal women.

  2011cites this paper
• The combinational effect of cardiac and biochemical markers in diabetic patients with cardiovascular disease

  2011cites this paper
• Angiotensin II receptor antagonism with telmisartan increases number of endothelial progenitor cells in normotensive patients with coronary artery disease: a randomized, double-blind, placebo-controlled study.

  2010cites this paper
• Influence of vitamin E supplementation on endothelial complications in type 2 diabetes mellitus patients who underwent coronary artery bypass graft.

  2009cites this paper
• Menopause and hormone therapy: from vascular endothelial function to cardiovascular disease.

  2009cites this paper
• EVALUATION OF CARDIAC RISK BY OXIDATIVE STRESS AND INFLAMMATORY MARKERS IN DIABETIC PATIENTS

  2009cites this paper
• Experimental Benefits of Sex Hormones on Vascular Function and the Outcome of Hormone Therapy in Cardiovascular Disease

  2008cites this paper
• l Diretriz brasileira sobre prevenção de doenças cardiovasculares em mulheres climatéricas e a influência da terapia de reposição hormonal (TRH) da Sociedade Brasileira de Cardiologia (SBC) e da Associação Brasileira do Climatério (SOBRAC)

  2008cites this paper
• Evaluation of C-Reactive Protein, Endothelin-1, Adhesion Molecule(s), and Lipids as Inflammatory Markers in Type 2 Diabetes Mellitus Patients

  2007cites this paper
• Time Since Menopause Influences the Acute and Chronic Effect of Estrogens on Endothelial Function

  2007cites this paper
• Hormones and cardiovascular health in women The ESHRE Capri Workshop Group 1

  2006cites this paper
• Hormones and cardiovascular health in women.

  2006cites this paper
• Chronic treatment with tadalafil improves endothelial function in men with increased cardiovascular risk.

  2005cites this paper
• Metformin improves endothelial function in patients with metabolic syndrome

  2005cites this paper
• Comparative vascular effects of hormone replacement therapy and raloxifene in women at increased cardiovascular risk

  2004cites this paper
• 25 – Hormone Replacement Therapy and Cardioprotection

  2004cites this paper
• Differential effects of progestins on hemostasis.

  2003cites this paper
• Effect of genistein on endothelial function in postmenopausal women: a randomized, double-blind, controlled study.

  2003cites this paper
• Hormone Replacement Therapy and Cardioprotection

  2003cites this paper
• Metabolic and vascular effect of progestins in post-menopausal women. Implications for cardioprotection.

  2003cites this paper
• Vascular reactivity in hypogonadal men is reduced by androgen substitution.

  2002cites this paper
• Different effect of hormone replacement therapy, DHEAS and tibolone on endothelial function in postmenopausal women with increased cardiovascular risk.

  2002cites this paper
• Dydrogesterone does not reverse the effects of estradiol on endothelium-dependant vasodilation in postmenopausal women: a randomised clinical trial.

  2002cites this paper